CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A Phase 1/2a, open-label, multicenter study of intramuscular (i.m.) PRL-02 depot in participants with advanced prostate cancer....
Phase 1, Phase 2
Jeffersonville, Indiana, United States and 13 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Jeffersonville, Indiana, United States and 131 other locations
patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...
Phase 3
Jeffersonville, Indiana, United States and 57 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Jeffersonville, Indiana, United States and 220 other locations
cemiplimab, or in combination with REGN5678. REGN4336, cemiplimab and REGN5678 are a type of treatment for cancer called immunotherapy,and ...
Phase 1, Phase 2
Louisville, Kentucky, United States and 10 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Jeffersonville, Indiana, United States and 388 other locations
A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 In The Treatment Of Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...
Phase 1
Louisville, Kentucky, United States and 100 other locations
in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy results in an imp...
Phase 3
Jeffersonville, Indiana, United States and 271 other locations
The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...
Phase 3
Jeffersonville, Indiana, United States and 202 other locations
assess the safety and efficacy of nivolumab in combination with rucaparib, docetaxel, or enzalutamide in participants with castration-resistant prostate...
Phase 2
Louisville, Kentucky, United States and 65 other locations
Clinical trials
Research sites
Resources
Legal